The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19

Mostrar otras versiones (1)

Introduction As the COVID-19 pandemic spread throughout the world, it was seen that patients who presented with critical disease had a higher incidence of thrombotic complications, associated with a poor prognosis. Currently prophylactic anticoagulation is recommended for all patients with COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Soto, Rodolfo, Aguilar-Soto, Mercedes, Demichelis, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
332.Anticoagulation and Antithrombotic Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330341/
http://dx.doi.org/10.1182/blood-2020-142594
Mostrar todas las versiones(2)

Ejemplares similares